We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
About this guideline
Overseas effective date: 16 Oct 2003
Categories: Clinical efficacy and safety | Blood products (including biotech alternatives)
Access this international scientific guideline
TGA annotations
If a sponsor believes that the patient numbers specified in this guideline are not achievable in Australia, advice should be sought from the TGA.
For more information see International scientific guidelines adopted in Australia.
Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.